Last reviewed · How we verify
Amoxicillin 250 MG
Amoxicillin 250 MG is a Small molecule drug developed by Ohio State University. It is currently FDA-approved. Also known as: Amoxicillin 250 mg Capsule, One-dose group.
At a glance
| Generic name | Amoxicillin 250 MG |
|---|---|
| Also known as | Amoxicillin 250 mg Capsule, One-dose group |
| Sponsor | Ohio State University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial (PHASE2)
- Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy (NA)
- Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT) (PHASE4)
- A Penicillin Allergy Delabeling Inhospital Model Hospitalized Patients (NA)
- Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute Malnutrition (NA)
- Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection (PHASE4)
- Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes (PHASE3)
- Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis)) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Amoxicillin 250 MG CI brief — competitive landscape report
- Amoxicillin 250 MG updates RSS · CI watch RSS
- Ohio State University portfolio CI
Frequently asked questions about Amoxicillin 250 MG
What is Amoxicillin 250 MG?
Amoxicillin 250 MG is a Small molecule drug developed by Ohio State University.
Who makes Amoxicillin 250 MG?
Amoxicillin 250 MG is developed and marketed by Ohio State University (see full Ohio State University pipeline at /company/ohio-state-university).
Is Amoxicillin 250 MG also known as anything else?
Amoxicillin 250 MG is also known as Amoxicillin 250 mg Capsule, One-dose group.
What development phase is Amoxicillin 250 MG in?
Amoxicillin 250 MG is FDA-approved (marketed).
Related
- Manufacturer: Ohio State University — full pipeline
- Also known as: Amoxicillin 250 mg Capsule, One-dose group
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing